Replies to post #318559 on Avid Bioservices Inc (CDMO)

[cheynew]

Good find Hutschi.

[cjgaddy]

Nice Find, Huts: 11-15-17/Outsourcing-Pharma article (re: SK/RL Interviews)
“How This R&D Company (Peregrine) is Transitioning to a Pure-Play CDMO: ‘Opportunities Are Almost Endless’" - Melissa Fassbender
Recap of interviews with Steve King & Avid Pres. Roger Lias http://tinyurl.com/y7dv9faz
...Excerpt: THE FUTURE AS A CDMO: Lias' 1st objective as the new Pres. of Avid will be to ramp up visibility & bus. dev., he told us. Short term, the strategy is to fully consolidate as a multi-product CDMO. As part of this, the company is currently looking to license or sell its proprietary R&D assets, including Bavituximab. “One of the first things we’ll do is bolster our capabilities for our early phase work,” said Lias. “We need more,” he added. Beyond that, Lias said the next steps will be aligning the organization to be able to better serve multiple clients. The company will grow organically and M&A is, “of course,” a potential, he explained. The company will also look diversify its service offerings and may deploy new “copycat” facilities, though no locations have been chosen at this time. “The opportunities are almost endless out there at the moment,” concluded Lias.
https://muckrack.com/melissa-fassbender

[north40000]

HCM, LLY, AZN: Anyone remember China? Oncology, immunotherapy are areas of focus for HCM—LLY and AZN are 2 collaborators, as broadcast by CNBC-TV, 2:30-2:40 ET. Are there more?

China has a huge Cancer population.
May be a fertile area to outsource for PPHM.

Then, too, there may be the connection between UTSW and BGNE that has been mentioned.

[sunstar]

AVID M&A mentioned separately by Lias and King, described as “a potential”, and “very hot” referencing the CDMO space.

https://www.outsourcing-pharma.com/Article/2017/11/15/Peregrine-transitioning-to-pure-play-CDMO?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright

Hutschi, Thanks for your excellent finds.

(If) both AVID and PPHM R&D, IP, etc. are in transition by way of M&A...

100% of PPHM will sit in shares held.

IMO

sunstar

[asmarterwookie]

look diversify

should be look to diversify.

Excellence is hard to find these days...

Thanks for the 1st PR from Peregirne from the new PR firm.

Grade "b".

wook

[hutschi]

Another one:

https://www.biopharma-reporter.com/Article/2017/11/16/Avid-letting-Peregrine-fly-off-as-it-focuses-on-bio-CDMO-business